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The objective of the present investigation was to determine
fetal and maternal plasma concentrations of nonglucose carbo-
hydrates and polyols in normal human pregnancies at term.
Uncomplicated human pregnancies (n 50) were studied at37
wk gestation. Blood samples were obtained from umbilical ar-
tery, umbilical vein, and maternal peripheral blood at the time of
elective cesarean section. Plasma concentrations of inositol,
glycerol, erythritol, sorbitol, and mannose were determined by
HPLC analysis. Differences between umbilical venous, umbilical
arterial, and maternal concentration were tested by the two-tailed
t test for paired samples. Correlations between umbilical and
maternal concentration and between umbilical venoarterial con-
centration difference and umbilical arterial concentration were
assessed by Pearson’s correlation and multiple regression anal-
ysis. All newborns were appropriate for gestational age, and
oxygenation and acid-base balance were within the normal range
for all fetuses studied. For most of the polyols (inositol, sorbitol,
and erythritol), the fetal concentration was significantly higher
than the maternal concentration. The umbilical venoarterial con-
centration difference for inositol was 10.5  3.6 M, for
glycerol was 10  1.7 M, for sorbitol was 3.8  0.5 M (p 
0.001), and for mannose was 7.6  0.7 M. There was a
significant correlation between maternal concentration and um-
bilical venous concentration of mannose (UVMAN  15.38 
0.69 MMAN; R2  0.46; p  0.001). These results indicate that
in normal human pregnancies at term, inositol is produced by the
fetus, sorbitol is produced by the placenta, and there is a signif-
icant umbilical uptake of mannose from the maternal circulation.
(Pediatr Res 58: 700–704, 2005)
Abbreviation
RBC, red blood cell
The transport of glucose across the human placenta has been
well studied in both normal and high-risk pregnancies (1–4).
However, the study of the other carbohydrates and sugar
alcohols in plasma has received far less attention. In part, this
may reflect the untested assumption that other carbohydrates
and polyols can be produced from glucose in sufficient
amounts to meet fetal requirements. One might assume, then,
that there is little need for a supply of these other compounds
to the fetus by placental transport. However, studies of the
nutritional supply of amino acids in early development have
emphasized that many amino acids that are considered “non-
essential” may be required in the dietary supply to the fetus or
the newborn (5,6). The same may be true of some carbohy-
drates. Recent studies have suggested that mammalian cells
may require an exogenous supply of mannose to meet mannose
6-phosphate requirements for glycoprotein synthesis (7). Fur-
thermore, the biologic importance of the polyols has received
attention with respect to their accumulation in reproductive
tissues (8–10) and to their roles in complications of diabetes
(11,12). A recent study demonstrated that a low maternal
serum inositol concentration is associated with a 2.6-fold
increased risk for offspring with spina bifida (13). In addition,
the increased risk for neural tube defects that is found in
mothers with diabetes could be explained by a secondary
cellular depletion of inositol as a result of an inhibited cellular
uptake from hyperglycemia (13).
However, there have been few studies in human pregnancies
of inositol and of sorbitol in terms of their maternal and fetal
concentrations (14–17). For the rest of the sugars and sugar
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alcohols, their concentrations in maternal and fetal plasma are
unknown. However, a recent study has shown that some of the
polyols are in relatively high concentration in human embry-
onic fluids, which suggests an important biologic role during
early development (18). The present study was directed at
determining the normal maternal–fetal concentration differ-
ences for these compounds, as well as establishing whether
there is any significant fetal or placental uptake of these sugars
and alcohols.
METHODS
Pregnant women were enrolled for the study at two different sites: 1) the
Department of Obstetrics and Gynecology, University of Milan, DMSD San
Paolo (Milan, Italy), and 2) the Department of Gynecology, Medical Univer-
sity of Bialystok (Bialystok, Poland). The reason for the two sites is that the
obstetricians in Milan and Bialystok had worked together in the Division of
Perinatal Medicine at the University of Colorado and the collaborative research
stemmed from this joint interaction. HPLC analyses were conducted at the
Perinatal Research Facility of the University of Colorado School of Medicine
(Aurora, CO). The protocol of the study was approved in advance by the
Ethical Committee of the San Paolo Hospital and by the Ethical Committee of
the Medical University of Bialystok. Informed consent was obtained from all
pregnant women.
Patients. Fifty uncomplicated singleton pregnancies were studied at term
(37 wk of gestation) at the time of elective cesarean section. All cesarean
sections were performed under peridural anesthesia. The indications for cesar-
ean section were breech presentation, one or more previous cesarean sections,
previous myomectomy, or placenta previa. Gestational age was calculated
from the last menstrual period and confirmed by routine ultrasound within 20
wk of gestation. Immediately after delivery of the newborn, umbilical arterial
and venous blood samples were obtained from a doubly clamped segment of
the cord. Simultaneously, maternal peripheral blood was obtained from a radial
artery or from an antecubital vein.
Analytical methods. Blood samples were collected into heparinized sy-
ringes or into preheparinized plastic tubes (Life Sciences, Denver, CO). Fetal
Hb concentration, oxygen saturation (O2 sat), umbilical arterial pH, PO2 and
PCO2 were measured on a Radiometer ABL 700 analyzer (Radiometer, Copen-
hagen, Denmark) in Italy and on a Ciba Corning 278 Blood Gas System (Ciba
Corning Diagnostics, Medfield, MA) in Poland. Within 10 min from collection
of the blood samples, plasma for carbohydrates and polyol analyses were
separated by centrifugation at 4°C and frozen at 70°C until the time of
analysis.
Plasma concentrations were determined mainly because almost all previous
studies of sugar and polyol concentrations had been carried out on plasma.
However, to test whether there was rapid exchange between plasma and red
blood cells (RBCs), we incubated human umbilical cord blood with 14C
labeled substrates at 37°C for up to 20 min. The latter time was taken as the
maximum time beginning with obtaining a sample and separating the plasma
and RBCs. Figure 1 presents the data for such a study and illustrates that there
was no evidence of rapid exchange between RBCs and plasma.
HPLC analysis. Plasma concentrations of glucose, inositol, glycerol, eryth-
ritol, sorbitol, and mannose were determined as previously described (19).
Plasma was quickly thawed, and 0.1 mL of plasma was deproteinized by
adding 0.1 mL of 0.3 N zinc sulfate that contained 30 mg/100 mL xylitol as
internal standard and mixed well. A total of 0.1 mL of 0.3 N barium hydroxide
then was added and mixed. After centrifugation at 14,000  g for 10 min, the
supernatant was filtered through a Millipore (Bedford, MA) filter (pore size
0.45 m) and loaded on a refrigerated autosampler of a Dionex HPLC (Dionex
Corp., Sunnyvale, CA). The separation of hexoses and polyols was carried out
on a CarboPac MA1 anion-exchange column. The analysis was run isocrati-
cally with 500 mM sodium hydroxide for 13 min, followed by a step change
to 300 mM sodium hydroxide for 20 min at ambient temperature. The flow rate
was 0.4 mL/h. All of the peaks were quantified using a pulse amperometric
detector with a gold working electrode. The Dionex PeakNet software was
used for instrument operation and data analysis. The concentrations of each
sugar were calculated by using the integrated area under the peak. The internal
xylitol standard was used to correct for instrument variances. All concentra-
tions were expressed in M. Figure 2 presents chromatograms of maternal and
fetal plasma achieved with this method using xylitol as an internal standard.
Calculations and statistical analysis. Umbilical venoarterial concentration
differences for carbohydrates and polyols were determined as Umb diff (M)
 UV  UA, where UV and UA are umbilical venous and arterial plasma
concentrations. Fetal–maternal concentration ratios were calculated as F/M 
UA/M, where UA is the umbilical arterial plasma concentration and M is the
maternal plasma concentration.
Data are presented as mean  SEM. An F test first was performed on all
data. Differences between the Italian and the Polish concentration data were
tested using the t test for unpaired samples. Differences between umbilical
venous, umbilical arterial, and maternal concentrations were analyzed for
significance with the two-tailed t test for paired samples.
Correlation between umbilical and maternal concentrations and between
umbilical concentration difference and umbilical arterial or venous concentra-
tions were assessed by Pearson’s correlation and multiple regression analysis.
A p  0.05 was considered significant.
RESULTS
A total of 28 patients were enrolled in Italy, and 22 were
enrolled in Poland. Characteristics of the studied population
are presented in Table 1. All newborns were appropriate for
Figure 1. Exchange of nonglucose carbohydrates and polyols between RBCs
and plasma. Human umbilical cord blood was incubated with 14C-labeled
substrates at 37°C for up to 20 min. A sample was obtained at different time
intervals, plasma was separated, and radioactivity was measured. The steady-
state curve shows that there is no evidence of rapid exchange of nonglucose
carbohydrates and polyols between RBCs and plasma. e, Inositol; Œ, man-
nose; X, sorbitol.
Figure 2. HPLC chromatograms of maternal (A) and fetal (B) plasma
depicting the peaks for the various sugars and polyols are presented. The much
higher peak for inositol in fetal blood is clearly evident in a comparison of the
two figures. Xylitol is included as an internal standard.
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gestational age according to Italian (20) and Polish (21) birth
weight–gestational age standards; oxygenation and acid-base
balance were within the normal range for all of the studied
fetuses according to data previously published (22).
Population differences. The differences for the data between
the Italian and the Polish population were confined to the
following maternal concentrations of inositol (Italian: 21.36 
1.6 M; Polish: 30.72  2.89 M; p  0.01) and mannose
(Italian: 60.51  1.90 M; Polish: 73.03  3.90 M; p 
0.01) and to umbilical venous concentrations of inositol (Ital-
ian: 60.76  3.21 M; Polish: 72.62  4.83 M; p  0.05)
and sorbitol (Italian: 13.82  0.96 M; Polish: 10.09  1.34
M; p  0.05). In contrast, umbilical venoarterial concentra-
tion differences and fetal–maternal concentration ratios were
not significantly different between the Italian and the Polish
data for all carbohydrates. In addition, the Polish and Italian
data were analyzed separately to confirm that significant um-
bilical venoarterial concentration difference, significant fetal–
maternal concentration ratio, and significant relationships
found in the pooled data were also found in the data analyzed
separately in the two sites. Therefore, the results from the two
groups have been pooled for analysis of these variables. Be-
cause, in the adult, there are no appreciable arteriovenous
concentration differences for all of the carbohydrates and poly-
ols that we considered, maternal arterial and venous samples
have been pooled together.
Fetal and maternal concentrations. Umbilical venous, um-
bilical arterial, and maternal plasma concentrations of glucose,
nonglucose carbohydrates, and polyols are presented in Table
2. Umbilical venous concentrations were significantly higher
than maternal concentrations for inositol (p 0.001), erythritol
(p  0.001), and sorbitol (p  0.001), whereas maternal
concentrations were significantly higher than umbilical venous
concentrations for glycerol (p  0.001) and mannose (p 
0.01). Figure 3 presents the fetal–maternal ratios for the car-
bohydrates and polyols.
Umbilical venoarterial differences. Umbilical venoarterial
concentration differences for nonglucose carbohydrates and
polyols are presented in Fig. 4. There was a significant negative
umbilical venous-arterial concentration difference for inositol
(10.5  3.6 M), suggesting fetal production of inositol.
Figure 4 also shows that, on the contrary, umbilical venous
concentration was significantly higher than arterial for glyc-
erol, sorbitol, and mannose.
There was a significant correlation between the umbilical
venous concentration and the maternal concentration of man-
nose (Fig. 5). Furthermore, there was a significant correlation
between the umbilical arterial and the umbilical venous con-
centration of mannose (UVMAN  2.53  0.91 UAMAN; R2
 0.89; p  0.001) but none between the umbilical venoarte-
rial concentration difference of mannose and the umbilical
venous concentration. Similarly, there was no significant cor-
relation of umbilical venous mannose concentration with either
the maternal or the umbilical venous concentration of glucose.
DISCUSSION
There have been many studies of the transplacental concen-
tration gradient for glucose in human pregnancies and in
animal studies (1–4,19). These studies have also determined
the relationship between glucose delivery to the fetus and the
maternal glucose concentration. However, there have been
virtually no comparable studies for the other carbohydrates,
including the polyols. This is surprising given that there has
been increasing evidence of the importance of nonglucose
carbohydrates and polyols for human tissues. For example,
studies in patients with diabetes have focused on the role of
changes in sorbitol and inositol tissue concentrations as caus-
ative factors in the diabetic complications of cataracts and
peripheral neuropathies, and individuals with diabetes have
been shown to have higher tissue sorbitol concentrations and
lower inositol concentrations compared with those without
diabetes (10,11). A patient with congenital cataracts has been
shown to have absent sorbitol dehydrogenase activity in the
lens. Transgenic mice expressing the aldose reductase gene,
which catalyzes the production of sorbitol from glucose, de-
velop susceptibility to diabetic and galactose cataracts (23).
Our study provides the first evidence of in vivo umbilical
uptake of sorbitol by the human placenta. Production of sor-
bitol by the human placenta has been shown in vitro by Mango
et al. (9) and Grimshaw and Lai (24). It is likely that the
umbilical uptake reflects placental production, although with-
out tracer studies and/or uterine arteriovenous concentration
Table 1. Clinical characteristics of the studied population
Italy Poland p
Patients number 28 22
Gestational age (weeks) 38.2 0.1 38.9 0.4 ns
Fetal weight (g) 3219  83 3325 77 ns
Placental weight (g) 482 20 — —
Fetal Hb (g/dl) 14.5  0.3 14.1 0.3 ns
UA pH 7.303  0.007 7.283 0.010 ns
UA pO2 (mmHg) 17.9  1.1 15.5 0.07 ns
UA pCO2 (mmHg) 51.9  1.1 54.6 1.8 ns
Table 2. Concentrations of carbohydrates and polyols in maternal peripheral blood (M), umbilical vein (UV) and umbilical artery (UA)
M UV UA P (MvsUA)
Glucose 4553.1  100.8 3590.5 82.6 2942.1 81.4 0.001
Inositol 25.74  1.75 64.42 2.5 75.43 3.6 0.001
Glycerol 127.35  15.17 33.48 1.91 23.5 1.83 0.001
Erythritol 7.74 1.02 11.19  1.02 12.64 1.20 0.001
Sorbitol 2.9  0.53 12.23  0.86 8.36 0.70 0.001
Mannose 66.37  2.28 60.73 2.23 53.09 2.16 0.001
Concentrations are expressed in M. Values are mean  SE. p-Values were determined by Student’s t-test for paired observations for maternal and umbilical
venous plasma concentrations.
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differences, we cannot exclude the unlikely possibility of trans-
port of this straight-chain alcohol from the maternal circula-
tion. In the present study, no correlation could be found
between maternal glucose concentration and the umbilical
uptake of sorbitol.
Inositol concentrations are known to be elevated during fetal
life and to decrease postnatally (12,13). Free inositol is present
in all tissues but is especially high in tissues whose cells do not
divide rapidly in adult life: CNS, skeletal muscle, and cardiac
muscle (12). The concentrations of inositol in these tissues are
very high at the earliest stages of development (12,13). The
enzyme required for the synthesis of inositol from glucose
(glucose-6-P cyclase) has been found in the human placenta
and umbilical cord (9,14). However, nothing is known about
whether fetal inositol requirements are met by placental trans-
port or by fetal production. The present study clearly estab-
lishes the importance of fetal production because there is no
significant umbilical uptake of inositol into the fetal circulation
despite the potential for placental production of inositol from
glucose.
The present study has documented a surprising finding for
mannose. This sugar is required for glycoprotein and glycoph-
ospholipid synthesis, and it can be synthesized from glucose.
Given its very low concentration in maternal blood, it was
logical to assume that fetal mannose requirements, like inositol
requirements, are met by fetal synthesis rather than by placen-
tal transport. However, the present study establishes that in
normal human pregnancies, there is a significant umbilical
uptake of mannose. Recent in vitro studies have brought out
two important new findings about mannose metabolism in
human tissues. One set of studies documented the presence of
a specific high-affinity mannose transporter in human fibro-
blasts (25). This transporter is capable of transporting mannose
into cells even at the low mannose concentrations present in
plasma. The characteristics of the transporter are distinct from
glucose transporters in that the mannose transporter has a high
affinity for mannose and a relatively low affinity for glucose.
Furthermore, the study of Ogier-Denis et al. (26) showed that
the mannose transporter is developmentally regulated in en-
terocytes. Our data demonstrating a significant umbilical up-
take of mannose at relatively low maternal concentrations
strongly suggest the presence of a mannose transporter in
human trophoblast. A second set of studies (7) showed that the
production of mannose glycans in human fibroblasts may
require the presence of mannose rather than its intracellular
production from glucose. Because mannose glycans accumu-
late in fetal tissues during development, the umbilical uptake of
mannose, shown for the first time in the present study, is
consistent with the requirement of an external supply of man-
nose to the fetus.
Finally, that polyol concentrations are elevated sufficiently
in fetal blood to lead to the establishment of relatively large
fetal–maternal concentration gradients for polyols such as ino-
sitol, sorbitol, and erythritol (Table 2) suggests that the tropho-
blast may be relatively impermeable to these compounds. The
presence of large fetal–maternal concentration ratios for the
polyols (Fig. 3) also suggests that the reduction of sugars to
their corresponding alcohols is favored. The role of the polyols
in developing tissues is currently unknown.
Figure 3. Fetal–maternal concentration ratios (F/M) of nonglucose carbohy-
drates and polyols in human pregnancies at term (mean  SE). Significances
of the difference of the ratio from 1 are presented.
Figure 4. Umbilical venoarterial concentration differences of nonglucose
carbohydrates and polyols in human pregnancies at term. Bar graphs are mean
 SE. p values for the concentration differences from 0 are presented.
Figure 5. Relationship between umbilical venous plasma mannose concen-
tration and maternal plasma mannose concentration: UVMAN  15.38  0.69
MMAN; R2  0.46; p  0.001. F, Italian data; ‚, Polish data.
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Glycerol is known to be taken up across the placenta. The
present study demonstrates the significant venoarterial concen-
tration difference of glycerol and also shows that glycerol
concentration gradient is from the maternal circulation to the
fetal circulation. This is in contrast to the other polyols dis-
cussed above. Whether the nonglucose carbohydrates have
altered metabolism in such diseases as maternal diabetes or
fetal growth restriction is also unknown and will require further
study.
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